South Korea
· Delayed Price · Currency is KRW GemVax&KAEL Co.,Ltd. Statistics
Total Valuation
GemVax&KAEL Co.,Ltd. has a market cap or net worth of KRW 479.33 billion. The enterprise value is 497.65 billion.
| Market Cap | 479.33B |
| Enterprise Value | 497.65B |
Important Dates
The last earnings date was Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
GemVax&KAEL Co.,Ltd. has 39.68 million shares outstanding. The number of shares has increased by 0.58% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 39.68M |
| Shares Change (YoY) | +0.58% |
| Shares Change (QoQ) | +0.56% |
| Owned by Insiders (%) | 3.50% |
| Owned by Institutions (%) | 6.22% |
| Float | 28.25M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.50 |
| PB Ratio | 5.90 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -9.48 |
| EV / Sales | 7.83 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -20.72 |
Financial Position
The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.45.
| Current Ratio | 1.08 |
| Quick Ratio | 0.76 |
| Debt / Equity | 0.45 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.54 |
| Interest Coverage | -30.76 |
Financial Efficiency
Return on equity (ROE) is -49.87% and return on invested capital (ROIC) is -17.28%.
| Return on Equity (ROE) | -49.87% |
| Return on Assets (ROA) | -15.54% |
| Return on Capital (ROIC) | -17.28% |
| Revenue Per Employee | 324.37M |
| Profits Per Employee | -267.92M |
| Employee Count | 196 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 5.90 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.41% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -15.41% |
| 50-Day Moving Average | 15,564.60 |
| 200-Day Moving Average | 12,477.45 |
| Relative Strength Index (RSI) | 36.19 |
| Average Volume (20 Days) | 1,004,509 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GemVax&KAEL Co.,Ltd. had revenue of KRW 63.58 billion and -52.51 billion in losses. Loss per share was -1,330.84.
| Revenue | 63.58B |
| Gross Profit | 17.84B |
| Operating Income | -34.87B |
| Pretax Income | -52.67B |
| Net Income | -52.51B |
| EBITDA | -30.57B |
| EBIT | -34.87B |
| Loss Per Share | -1,330.84 |
Balance Sheet
The company has 18.61 billion in cash and 36.93 billion in debt, giving a net cash position of -18.32 billion or -461.67 per share.
| Cash & Cash Equivalents | 18.61B |
| Total Debt | 36.93B |
| Net Cash | -18.32B |
| Net Cash Per Share | -461.67 |
| Equity (Book Value) | 81.26B |
| Book Value Per Share | 2,047.93 |
| Working Capital | 2.53B |
Cash Flow
In the last 12 months, operating cash flow was -20.68 billion and capital expenditures -3.35 billion, giving a free cash flow of -24.02 billion.
| Operating Cash Flow | -20.68B |
| Capital Expenditures | -3.35B |
| Free Cash Flow | -24.02B |
| FCF Per Share | -605.36 |
Margins
Gross margin is 28.05%, with operating and profit margins of -54.84% and -82.59%.
| Gross Margin | 28.05% |
| Operating Margin | -54.84% |
| Pretax Margin | -82.85% |
| Profit Margin | -82.59% |
| EBITDA Margin | -48.08% |
| EBIT Margin | -54.84% |
| FCF Margin | -37.78% |
Dividends & Yields
GemVax&KAEL Co.,Ltd. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.58% |
| Shareholder Yield | -0.58% |
| Earnings Yield | -11.02% |
| FCF Yield | -5.01% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
GemVax&KAEL Co.,Ltd. has an Altman Z-Score of 3.53.
| Altman Z-Score | 3.53 |
| Piotroski F-Score | n/a |